Novartis lung drug has similar efficacy to rival

Swiss drugmaker Novartis AG experimental lung drug NVA237 helps patients with a life threatening respiratory disease in a similar way to a rival drug from Pfizer and Boehringer Ingelheim, a late-stage study showed.

View full post on Yahoo! Health News

, , , , ,

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Get Adobe Flash player

Powered by Yahoo! Answers

© 1992-2012 DC2NET™, Inc. All Rights Reserved